TLDR Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.
Pseudopelade of Brocq is a rare form of scarring alopecia characterized by patchy hair loss without significant inflammation. The case report described a 20-year-old male with a 2-year history of progressive hair loss and mild itching. The condition is challenging to diagnose and treat, often being the end result of other inflammatory conditions like lichen planus or lupus erythematosus. Histopathological features include the absence of marked inflammation and the presence of fibrotic streams. Treatment options, including intralesional steroids, showed poor efficacy, and the condition remains largely irreversible. Autografting and other surgical techniques have limited success, highlighting the need for more effective management strategies.
254 citations,
December 2003 in “Journal of the American Academy of Dermatology” Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.
1 citations,
August 2022 in “JAAD case reports” Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.
April 2022 in “Journal of Cosmetic Dermatology” Trimax-360 Serum, when used for 98 days, safely and effectively improves hair growth, thickness, and density without any side effects.
5 citations,
January 2020 in “Journal of Dermatology” Temporal hair loss relates to overall scalp hair loss in women.
41 citations,
December 2008 in “International Journal of Dermatology” South Korean women with hair loss have lower hair density and thickness compared to healthy women.
28 citations,
September 1998 in “Medical Clinics of North America” Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.
October 1990 in “Archives of Dermatology” Hair loss and growth can be accurately measured using computer-assisted counting.
5 citations,
October 1988 in “Clinics in Dermatology” Minoxidil promotes hair growth but exact mechanism is unknown.